C-type natriuretic peptide (CNP) suppresses plasminogen activator inhibitor-1 (PAI-1) in vivo

Cardiovascular Research

Volumn 66, Issue 3, 2005, Pages 574-582

  Kairuz, Evette M ^a   Barber, Melissa N ^a,b   Anderson, Colin R ^a   Kanagasundaram, Meetali ^a   Drummond, Grant R ^a,b   Woods, Robyn L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Atherosclerosis; Endothelium; Intimal hyperplasia; Macrophages; NADPH oxidase; Neointima; Restenosis; Superoxide

Indexed keywords

NATRIURETIC PEPTIDE TYPE C; PLASMINOGEN ACTIVATOR INHIBITOR 1; SODIUM CHLORIDE; SUPEROXIDE;

ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL WALL; CAROTID ARTERY; CELL INFILTRATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; DENSITOMETRY; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; INFUSION; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SPACE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; CHEMILUMINESCENT MEASUREMENTS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MODELS, ANIMAL; NATRIURETIC PEPTIDE, C-TYPE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATORS; RABBITS; SUPEROXIDES; TUNICA INTIMA;

EID: 19444375971     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.01.024     Document Type: Article

References (38)

1. K. Okahara, J. Kambayashi, T. Ohnishi, Y. Fujiwara, T. Kawasaki, and M. Monden Shear stress induces expression of CNP gene in human endothelial cells FEBS Lett 373 1995 108 110
2. S. Suga, H. Itoh, Y. Komatsu, Y. Ogawa, N. Hama, and T. Yoshimasa Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells-evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells Endocrinology 133 1993 3038 3041
3. J.G. Drewett, B.M. Fendly, D.L. Garbers, and D.G. Lowe Natriuretic peptide receptor-B (guanylyl cyclase-B) mediates C-type natriuretic peptide relaxation of precontracted rat aorta J Biol Chem 270 1995 4668 4674
4. M. Furuya, M. Takehisa, Y. Minamitake, Y. Kitajima, Y. Hayashi, and N. Ohnuma Novel natriuretic peptide, CNP, potently stimulates cyclic GMP production in rat cultured vascular smooth muscle cells Biochem Biophys Res Commun 170 1990 201 208
5. M. Ikeda, M. Kohno, K. Yasunari, K. Yokokawa, T. Horio, and M. Ueda Natriuretic peptide family as a novel antimigration factor of vascular smooth muscle cells Arterioscler Thromb Vasc Biol 17 1997 731 736
6. M. Furuya, M. Yoshida, Y. Hayashi, N. Ohnuma, N. Minamino, and K. Kangawa C-type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells Biochem Biophys Res Commun 177 1991 927 931
7. K. Doi, H. Itoh, T. Ikeda, K. Hosoda, Y. Ogawa, and T. Igaki Adenovirus-mediated gene transfer of the C-type natriuretic peptide causes G1 growth inhibition of cultured vascular smooth muscle cells Biochem Biophys Res Commun 239 1997 889 894
8. M. Kohno, T. Horio, K. Yokokawa, N. Kurihara, and T. Takeda C-type natriuretic peptide inhibits thrombin- and angiotensin II-stimulated endothelin release via cyclic guanosine 3′,5′-monophosphate Hypertension 19 1992 320 325
9. M. Kohno, K. Yokokawa, K. Yasunari, H. Kano, M. Minami, and M. Ueda Effect of natriuretic peptide family on the oxidized LDL-induced migration of human coronary artery smooth muscle cells Circ Res 81 1997 585 590
10. M. Shinomiya, J. Tashiro, Y. Saito, S. Yoshida, M. Furuya, and N. Oka C-type natriuretic peptide inhibits intimal thickening of rabbit carotid artery after balloon catheter injury Biochem Biophys Res Commun 205 1994 1051 1056
11. H. Ueno, A. Haruno, N. Morisaki, M. Furuya, K. Kangawa, and A. Takeshita Local expression of C-type natriuretic peptide markedly suppresses neointimal formation in rat injured arteries through an autocrine/paracrine loop Circulation 96 1997 2272 2279
12. K. Doi, T. Ikeda, H. Itoh, K. Ueyama, K. Hosoda, and Y. Ogawa C-type natriuretic peptide induces redifferentiation of vascular smooth muscle cells with accelerated reendothelialization Arterioscler Thromb Vasc Biol 21 2001 930 936
13. J.L. Bouchie, H. Hansen, and E.P. Feener Natriuretic factors and nitric oxide suppress plasminogen activator inhibitor-1 expression in vascular smooth muscle cells-role of cGMP in the regulation of the plasminogen system Arterioscler Thromb Vasc Biol 18 1998 1771 1779
14. M. Yoshizumi, H. Tsuji, H. Nishimura, H. Masuda, Y. Kunieda, and H. Kawano Natriuretic peptides regulate the expression of tissue factor and PAI-1 in endothelial cells Thromb Haemost 82 1999 1497 1503
15. M.B. DeYoung, C. Tom, and D.A. Dichek Plasminogen activator inhibitor type 1 increases neointima formation in balloon-injured rat carotid arteries Circulation 104 2001 1972 1981
16. H. Sawa, C. Lundgren, B.E. Sobel, and S. Fujii Increased intramural expression of plasminogen activator inhibitor type 1 after balloon injury: a potential progenitor of restenosis J Am Coll Cardiol 24 1994 1742 1748
17. J. Schneiderman, M.S. Sawdey, M.R. Keeton, G.M. Bordin, E.F. Bernstein, and Dilley Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries Proc Natl Acad Sci U.S.A. 89 1992 6998 7002
18. T. Padro, J.J. Emeis, M. Steins, K.W. Schmid, and J. Kienast Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic disease Arterioscler Thromb Vasc Biol 15 1995 893 902
19. J.P. Irigoyen, P. Munoz-Canoves, L. Montero, M. Koziczak, and Y. Nagamine The plasminogen activator system: biology and regulation Cell Mol Life Sci 56 1999 104 132
20. A.F. Drew, H.L. Tucker, K.W. Kombrinck, D.I. Simon, T.H. Bugge, and J.L. Degen Plasminogen is a critical determinant of vascular remodeling in mice Circ Res 87 2000 133 139
21. R.F. Booth, J.F. Martin, A.C. Honey, D.G. Hassall, J.E. Beesley, and S. Moncada Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation Atherosclerosis 76 1989 257 268
22. G.J. Dusting, A. Curcio, P.J. Harris, B. Lima, M. Zambetis, and J.F. Martin Supersensitivity to vasoconstrictor action of serotonin precedes the development of atheroma-like lesions in the rabbit J Cardiovasc Pharmacol 16 1990 667 674
23. G.R. De Meyer, H. Bult, A.E. Van Hoydonck, F.H. Jordaens, N. Buyssens, and A.G. Herman Neointima formation impairs endothelial muscarinic receptors while enhancing prostacyclin-mediated responses in the rabbit carotid artery Circ Res 68 1991 1669 1680
24. J. Arthur, and G.J. Dusting Selective endothelial dysfunction in early atheroma-like lesions in the rabbit Coron Artery Dis 3 1992 623 629
25. T.M. Paravicini, L.M. Gulluyan, G.J. Dusting, and G.R. Drummond Increased NADPH oxidase activity, gp91phox expression, and endothelium-dependent vasorelaxation during neointima formation in rabbits Circ Res 91 2002 54 61
26. G.R. De Meyer, and H. Bult Mechanisms of neointima formation-lessons from experimental models Vasc Med 2 1997 179 189
27. M.N. Barber, T.A. Gaspari, E.M. Kairuz, G.J. Dusting, and R.L. Woods Atrial natriuretic peptide preserves endothelial function during intimal hyperplasia J Vasc Res 42 2 2005 101 110 [Epub ahead of print]
28. H. Sjoland, D. Eitzman, D. Gordon, R. Westrick, E.G. Nabel, and D. Ginsburg Atherosclerosis progression in LDL-receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1 Arterioscler Thromb Vasc Biol 20 2000 846 852
29. D. Hasenstab, H. Lea, and AW. Clowes Local plasminogen activator inhibitor type 1 overexpression in rat carotid artery enhances thrombosis and endothelial regeneration while inhibiting intimal thickening Arterioscler Thromb Vasc Biol 20 2000 853 859
30. P.G. Tipping, P. Davenport, M. Gallicchio, E.L. Filonzi, J. Apostolopoulos, and J. Wojta Atheromatous plaque macrophages produce plasminogen activator inhibitor type-1 and stimulate its production by endothelial cells and vascular smooth muscle cells Am J Pathol 143 1993 875 885
31. J.Y. Qian, A. Haruno, Y. Asada, T. Nishida, Y. Saito, and T. Matsuda Local expression of C-type natriuretic peptide suppresses inflammation, eliminates shear stress-induced thrombosis, and prevents neointima formation through enhanced nitric oxide production in rabbit injured carotid arteries Circ Res 91 2002 1063 1069
32. A.K. Kiemer, and A.M. Vollmar Effects of different natriuretic peptides on nitric oxide synthesis in macrophages Endocrinology 138 1997 4282 4290
33. M.A. Shatos, J.M. Doherty, D.C. Stump, E.A. Thompson, and D. Collen Oxygen radicals generated during anoxia followed by reoxygenation reduce the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cell culture J Biol Chem 265 1990 20443 20448
34. phox-containing NADPH oxidase Circ Res 89 2001 47 54
35. C.J. Wiedermann, M. Niedermuhlbichler, H. Braunsteiner, and C.J. Widermann Priming of polymorphonuclear neutrophils by atrial natriuretic peptide in vitro J Clin Invest 89 1992 1580 1586
36. H.H. Davila, T.R. Magee, D. Vernet, J. Rajfer, and N.F. Gonzalez-Cadavid Gene transfer of inducible nitric oxide synthase complementary DNA regresses the fibrotic plaque in an animal model of Peyronie's disease Biol Reprod 71 2004 1568 1577
37. M. Furuya, T. Miyazaki, N. Honbou, K. Kawashima, T. Ohno, and S. Tanaka C-type natriuretic peptide inhibits intimal thickening after vascular injury Ann N Y Acad Sci 748 1995 517 523
38. H. Takeuchi, K. Ohmori, I. Kondo, A. Oshita, K. Shinomiya, and Y. Yu Potentiation of C-type natriuretic peptide with ultrasound and microbubbles to prevent neointimal formation after vascular injury in rats Cardiovasc Res 58 2003 231 238